Avidian Wealth Enterprises
VRTX icon

Avidian Wealth Enterprises’s Vertex Pharmaceuticals VRTX Stock Holding History

Avidian Wealth Enterprises’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.09M Buy
2,080
+271
+15% +$139K 0.03% 317
2026
Q2 		$899K Buy
1,809
+74
+4% +$32.8K 0.02% 344
2026
Q1 		$775K Buy
1,735
+381
+28% +$178K 0.02% 337
2025
Q4 		$614K Buy
1,354
+97
+8% +$41.8K 0.02% 329
2025
Q3 		$492K Buy
1,257
+65
+5% +$27.2K 0.02% 369
2025
Q2 		$531K Sell
1,192
-33
-3% -$15.2K 0.02% 321
2025
Q1 		$594K Buy
1,225
+25
+2% +$11.6K 0.03% 279
2024
Q4 		$483K Buy
1,200
+58
+5% +$26.9K 0.02% 298
2024
Q3 		$531K Sell
1,142
-111
-9% -$53.3K 0.02% 288
2024
Q2 		$587K Buy
1,253
+740
+144% +$321K 0.02% 258
2024
Q1 		$214K Buy
+513
New +$217K 0.01% 411
2022
Q1 		– Sell
-985
Closed -$216K – 581
2021
Q4 		$216K Buy
+985
New +$192K 0.01% 481
2018
Q4 		– Sell
-6,108
Closed -$1.18M – 119
2018
Q3 		$1.18M Buy
6,108
+404
+7% +$71.9K 0.37% 28
2018
Q2 		$969K Buy
+5,704
New +$884K 0.31% 32

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return

Avidian Wealth Enterprises's VRTX Position: Q3 2026 in Review

Avidian Wealth Enterprises increased its Vertex Pharmaceuticals (VRTX) stake by 15% in Q3 2026, buying an estimated $139K and bringing the position to 2,080 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #317.

Avidian Wealth Enterprises first reported a position in VRTX in Q2 2018 and has held it in 14 quarters since. The position peaked at $1.18M in Q3 2018. 818 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Avidian Wealth Enterprises held 2,080 shares of Vertex Pharmaceuticals worth $1.09M as of Q3 2026.
  • Avidian Wealth Enterprises bought 271 Vertex Pharmaceuticals shares in Q3 2026, an estimated $139K.
  • Vertex Pharmaceuticals made up 0.03% of Avidian Wealth Enterprises's portfolio in Q3 2026, its #317 holding.
  • Avidian Wealth Enterprises first reported a position in Vertex Pharmaceuticals in Q2 2018 and has held it in 14 quarters since.
  • Avidian Wealth Enterprises's Vertex Pharmaceuticals position peaked at $1.18M in Q3 2018.
  • 818 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q3 2026, filed 8 Oct 2026.